Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force - Strehl, C; Bijlsma, JW; de Wit, M (Ann Rheum Dis, 2016)
March 1. [Epub ahead of print].